National Pharmaceutical Council: Comparative Effectiveness Research and the Environment for Health Care Decision Making
Eugene Rich discusses the CER landscape.
During this webinar, Eugene Rich and other experts reviewed findings from the National Pharmaceutical Council's fourth annual survey of health care stakeholders on comparative effectiveness research and the environment for health care decision making. Discussion topics included:
- Which organizations are considered key players in funding, monitoring and developing standards for comparative effectiveness research (CER)?
- Do health care stakeholders think that CER is already having an impact on decision-making, or do they expect to see that impact in the future?
- How have stakeholder perceptions of CER changed during the last four years?
